Drug profile · INN
interferon gamma-1b
IMUKIN
interferon gamma-1b (IMUKIN) is a interferon gamma receptor agonist. Route of administration: single-use. Current US regulatory status: approved.
Drug details — interferon gamma-1b
- US status
- approved
- Class
- —
- Route
- SINGLE-USE
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
interferon gamma-1b (IMUKIN) is a interferon gamma receptor agonist. Route of administration: single-use. Current US regulatory status: approved.
Key facts
Mechanism of action
Interferon gamma receptor agonist
Primary target: Interferon gamma receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is interferon gamma-1b?
interferon gamma-1b (IMUKIN) is a interferon gamma receptor agonist. Route of administration: single-use. Current US regulatory status: approved.
What is the brand name for interferon gamma-1b?
IMUKIN is a marketed brand name for interferon gamma-1b. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of interferon gamma-1b?
interferon gamma-1b has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.